Idiopathic Intracranial Hypertension

2023
  • Completed IN CNS rat exposure studies
2024
  • Completed IN CNS 3-month rat toxicology study
2025
  • Completed IN CNS 14-day maximum tolerated dose canine toxicology study
  • Initiated IN CNS 3-month canine toxicology study — estimated completion Q4
  • Initiated IN Phase 1 PK, PD, dose, & safety clinical trial in 20 healthy subjects – estimated completion Q4
2026
  • To be initiated IN Phase 2 double-blind, placebo-controlled 3-month safety and efficacy clinical trial in 36 IIH patients – estimated completion Q4